HPV16 E7 (86-93) (TFA)
This HLA-A2.1-restricted peptide, derived from the HPV16 E7 oncoprotein, demonstrates immunogenicity in cervical cancer models. It is a key research tool for studying antigen-specific T-cell responses, vaccine development, and immunotherapy mechanisms in both in vitro and in vivo experimental settings.
Product Specifications
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Molecular Weight
929.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
481824 100 µL
GJB1 (Gap Junction beta-1 Protein, Gap Junction Protein, beta 1, 32kD)
Sign In for Pricing
View Details